Stay updated on MOD-4023 Clinical Trial in Adult Growth Hormone Deficiency
Sign up to get notified when there's something new on the MOD-4023 Clinical Trial in Adult Growth Hormone Deficiency page.

Latest updates to the MOD-4023 Clinical Trial in Adult Growth Hormone Deficiency page
- Check3 days agoChange DetectedUpdated page revision to v3.0.2 (replacing v3.0.1); removed the 'Back to Top' element.SummaryDifference0.3%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.3%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new information on drug safety and specific pharmaceutical preparations like Somatrogon and MOD-4023. Notably, previous location details and references to certain medical conditions have been removed.SummaryDifference3%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to include new information about a clinical study, specifically the termination of the LT-OLE study and details about a Phase 3 study evaluating MOD-4023 for adults with growth hormone deficiency.SummaryDifference100%
Stay in the know with updates to MOD-4023 Clinical Trial in Adult Growth Hormone Deficiency
Enter your email address, and we'll notify you when there's something new on the MOD-4023 Clinical Trial in Adult Growth Hormone Deficiency page.